Regulus Therapeutics Soars 90% On Hepatitis C Treatment News
October 22, 2014 at 10:39 AM EDT
Regulus Therapeutics Inc(NASDAQ: RGLS) announced a breakthrough Wednesday in its hepatitis C treatment, which sent the stock ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.